Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - NET INCOME
Net Income ALNY - Alnylam Pharmaceuticals, Inc.
-278 M
LAST VALUE
50.41%
2 YEAR CAGR
20.68%
5 YEAR CAGR
2.56%
10 YEAR CAGR